Neuropeptide S alleviates neuropathic pain through lateral hypothalamic orexinergic circuit in rats

Abstract

Neuropathic pain poses a significant clinical challenge due to limited treatment options. Neuropeptide S (NPS) system is known to modulate pain and related affective states; however, the underlying mechanisms remain unexplained. NPS activates lateral hypothalamic (LH) orexinergic neurons involved in feeding, drug seeking, and stress-induced analgesia. Herein, we test the hypothesis that pain modulatory action of NPS is mediated by the LH-orexinergic system. Neuropathic pain was induced in rats via chronic constriction injury (CCI) of the sciatic nerve and the response was investigated using paw withdrawal latency (PWL) and paw withdrawal threshold (PWT). Decreased expression of NPS protein and NPS receptor mRNA was observed in the LH of CCI rats. Intra-LH injection of NPS to CCI rats significantly increased the PWL and PWT, while NPSR antagonist SHA-68 exacerbated the responses. Orexin-1/2 receptor antagonist (intra-ventrolateral periaqueductal gray (vlPAG) blocked the antinociceptive effect of NPS. However, infusion of SB-334867 into the nucleus accumbens and ventral tegmental area, the primary targets of orexinergic fibres, resulted in partial blockade. To test whether NPS in the LH activates the orexinergic projection to the vlPAG, Fast Blue was injected into the vlPAG and the fibers were retrogradely traced to orexin neurons in the LH. Intra-LH administration of NPS to CCI rats resulted in increased expression of cFos in the orexin neurons. The vlPAG in CCI rats showed elevated GABA and reduced glutamate; the changes were reversed following intra-LH NPS administration. We suggest that the NPS system, acting via LH-vlPAG orexinergic circuit, may alleviate neuropathic pain.